Depending on your Point of View, $271 Million is a lot of money. Before ruining millions of vaccines, Emergent failed inspections, raked in cash | Ars Technica
When contract-manufacturer Emergent BioSolutions contaminated at least 15 million doses of Johnson & Johnson’s COVID-19 vaccine and millions more doses of AstraZeneca’s vaccine at its Baltimore facility earlier this year, the company had been collecting monthly payments of $27 million from the US government—payments intended to help Emergent avoid just such a manufacturing disaster.
The were hired - or at least paid - by the .gov to manufacture 2 COVID-19 vaccines. It was a disaster. Contaminated raw materials. Unsanitary manufacturing. There are 70 million vaccines which are of questionable safety.
The US Department of Health and Human Services, which awarded Emergent the May 2020 grant, has since cut the reservation fee payments. The department did so after learning of the ruinous contamination at the Baltimore plant. But by that time, HHS had already paid Emergent monthly maintenance fees totaling $271 million.
Oversight? This is the government.
No comments:
Post a Comment
Comment Moderation is in place. Your comment will be visible as soon as I can get to it. Unless it is SPAM, and then it will never see the light of day.
Be Nice. Personal Attacks WILL be deleted. And I reserve the right to delete stuff that annoys me.